Nuclear receptors as therapeutic targets in cholestatic liver diseases

Por Zollner, Gernot, Trauner, Michael
Publicado em 2009

Recent advances in understanding and managing cholestasis

Por Wagner, Martin, Trauner, Michael
Publicado no F1000Res (2016)

Primary sclerosing cholangitis – The arteriosclerosis of the bile duct?

Por Fickert, Peter, Moustafa, Tarek, Trauner, Michael
Publicado em 2007

Bile acid transporters and regulatory nuclear receptors in the liver and beyond

Por Halilbasic, Emina, Claudel, Thierry, Trauner, Michael
Publicado em 2013

Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

Por Halilbasic, Emina, Baghdasaryan, Anna, Trauner, Michael
Publicado em 2013

Clinical application of transcriptional activators of bile salt transporters()

Por Baghdasaryan, Anna, Chiba, Peter, Trauner, Michael
Publicado em 2014

An In Silico Classification Model for Putative ABCC2 Substrates

Por Pinto, Marta, Trauner, Michael, Ecker, Gerhard F
Publicado em 2012

Fibrosis in Autoimmune and Cholestatic Liver Disease

Por Penz-Österreicher, Melitta, Österreicher, Christoph H., Trauner, Michael
Publicado em 2011

Pathogenesis of primary sclerosing cholangitis

Por Pollheimer, Marion J., Halilbasic, Emina, Fickert, Peter, Trauner, Michael
Publicado em 2011

Cystic Fibrosis Related Liver Disease—Another Black Box in Hepatology

Por Staufer, Katharina, Halilbasic, Emina, Trauner, Michael, Kazemi-Shirazi, Lili
Publicado em 2014

Difficult case of Cronkhite-Canada syndrome with small intestinal bacterial overgrowth, Clostridium difficile infection and polymyalgia rheumatica

Por Traussnigg, Stefan, Dolak, Werner, Trauner, Michael, Kazemi-Shirazi, Lili
Publicado no BMJ Case Rep (2016)

Cancer and liver cirrhosis: implications on prognosis and management

Por Pinter, Matthias, Trauner, Michael, Peck-Radosavljevic, Markus, Sieghart, Wolfgang
Publicado no ESMO Open (2016)

Liver Capsule: FXR agonists against liver disease

Por Fuchs, Claudia D., Schwabi, Philipp, Reiberger, Thomas, Trauner, Michael
Publicado no Hepatology (2016)

Pharmacological correction of misfolding of ABC proteins()

Por Rudashevskaya, Elena L., Stockner, Thomas, Trauner, Michael, Freissmuth, Michael, Chiba, Peter
Publicado em 2014

Cytokeratins as Targets for Bile Acid-Induced Toxicity

Por Fickert, Peter, Trauner, Michael, Fuchsbichler, Andrea, Stumptner, Conny, Zatloukal, Kurt, Denk, Helmut
Publicado em 2002

Bile Acid-Induced Mallory Body Formation in Drug-Primed Mouse Liver

Por Fickert, Peter, Trauner, Michael, Fuchsbichler, Andrea, Stumptner, Conny, Zatloukal, Kurt, Denk, Helmut
Publicado em 2002

Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

Por Arab, Juan P., Karpen, Saul J., Dawson, Paul A., Arrese, Marco, Trauner, Michael
Publicado no Hepatology (2016)

Loss of CFTR Affects Biliary Epithelium Innate Immunity and Causes TLR4–NF-κB–Mediated Inflammatory Response in Mice

Por Fiorotto, Romina, Scirpo, Roberto, Trauner, Michael, Fabris, Luca, Hoque, Rafaz, Spirli, Carlo, Strazzabosco, Mario
Publicado em 2011

LITHOCHOLIC ACID FEEDING RESULTS IN DIRECT HEPATO-TOXICITY INDEPENDENT OF NEUTROPHIL FUNCTION IN MICE

Por Woolbright, Benjamin L., Li, Feng, Xie, Yuchao, Farhood, Anwar, Fickert, Peter, Trauner, Michael, Jaeschke, Hartmut
Publicado em 2014

Hepatotoxicity of NONI juice: Report of two cases

Por Stadlbauer, Vanessa, Fickert, Peter, Lackner, Carolin, Schmerlaib, Jutta, Krisper, Peter, Trauner, Michael, Stauber, Rudolf E
Publicado no World J Gastroenterol (2005)